"We know that every consumer on a health journey has individualized needs and considerations, and having options to support those needs will continue to play an important role," said Tom Moe, President, Nestl USA Meals Division
Authors Note
Continuing semaglutide treatment is still recommended as it will likely allow weight loss to resume over time
Whilst no medications are currently licensed specifically for fatty liver disease in the UK, GLP-1 receptor agonistsoriginally developed for type 2 diabetesshow promising benefits for liver health
The US has not been left behind in this race, with people of color actively seeking out treatment for skin lightening
The focus is on working with our health coaches, behavioral health specialists, and the patients themselves to find out what they want to achieve, then encouraging them in those first steps, Johnson says